A.R.T. Advisors’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-24,600
Closed -$902K 1440
2019
Q3
$902K Buy
24,600
+16,400
+200% +$650K 0.05% 597
2019
Q2
$381K Sell
8,200
-59,443
-88% -$2.79M 0.02% 856
2019
Q1
$2.72M Buy
67,643
+17,200
+34% +$772K 0.16% 159
2018
Q4
$2.32M Buy
50,443
+41,400
+458% +$1.99M 0.15% 196
2018
Q3
$401K Buy
+9,043
New +$415K 0.02% 938
2018
Q2
Sell
-50,143
Closed -$3.63M 1519
2018
Q1
$3.63M Buy
+50,143
New +$3.68M 0.15% 179
2017
Q4
Sell
-30,560
Closed -$1.53M 1448
2017
Q3
$1.53M Sell
30,560
-24,900
-45% -$1.2M 0.08% 364
2017
Q2
$2.57M Buy
+55,460
New +$2.04M 0.14% 203
2016
Q3
Sell
-23,650
Closed -$233K 792
2016
Q2
$233K Sell
23,650
-177,208
-88% -$2.94M 0.01% 1051
2016
Q1
$3.4M Buy
200,858
+97,112
+94% +$1.56M 0.15% 189
2015
Q4
$2.31M Buy
103,746
+69,713
+205% +$1.76M 0.11% 247
2015
Q3
$802K Buy
+34,033
New +$2.14M 0.03% 705
2015
Q2
Sell
-43,696
Closed -$4.05M 1539
2015
Q1
$4.05M Buy
43,696
+9,255
+27% +$597K 0.14% 194
2014
Q4
$1.39M Buy
+34,441
New +$1.05M 0.05% 513

Other funds holding ESPR